InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

JD

Jin David

US·SEC (Form 4)

Fortress Biotech, Inc.Avenue Therapeutics, INC.

Cumul. flow

0

Total declarations

0

Companies

€34,100

▲ Purchases (3 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

3

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Browse the complete record of transactions filed by Jin David. Director active across 2 companies, notably Fortress Biotech, Inc.. Aggregated, 10 filings have been logged. Split: 3 buys · 0 sell. Total volume traded: €34k. History available since 26 October 2022. The latest transaction was disclosed on 1 April 2025 (Attribution). Regulator: SEC (Form 4). All data is free.

Declarations10 total

◆

Chief Financial OfficerExecutives1 Apr 2025Fortress Biotech, Inc.

$6,07826SEC ↗

5,000 shares@ US$1.215512.1% of flowCommon Stock, par value $0.001SEC:0001415889-25-009369:0

◆

Chief Financial OfficerExecutives19 Dec 2024Fortress Biotech, Inc.

1,000,000 shares0Common Stock, par value $0.001SEC:0001415889-24-030071:0

◆

Chief Financial OfficerExecutives1 Oct 2024Fortress Biotech, Inc.

$3,22426SEC ↗

2,625 shares@ US$1.22836.3% of flowCommon Stock, par value $0.001SEC:0001415889-24-024183:0

◆

Interim PFO and COOExecutives23 Sept 2024Avenue Therapeutics, INC.

65,000 shares0COMMON STOCK, PAR VALUE $0.0001SEC:0001104659-24-102834:0

▲

Chief Financial OfficerExecutives10 Jul 2024Fortress Biotech, Inc.

$3,75036SEC ↗

500 shares@ US$7.507.5% of flowSERIES A CUMULATIVE PERPETUAL PREFERRED STOCKSEC:0001104659-24-079409:0

Ideal exit: 6 Apr 2025 (T+270)

◆

Chief Financial OfficerExecutives1 Apr 2024Fortress Biotech, Inc.

$3,99824SEC ↗

2,352 shares@ US$1.708.0% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-24-042504:0

◆

Chief Financial OfficerExecutives20 Dec 2023Fortress Biotech, Inc.

140,000 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-128788:0

▲

Chief Financial OfficerExecutives10 Feb 2023Fortress Biotech, Inc.

$30,00049SEC ↗

35,928 shares@ US$0.83560.2% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-23-021541:0

Ideal exit: 7 Nov 2023 (T+270)

▲

Chief Financial OfficerExecutives30 Nov 2022Fortress Biotech, Inc.

$2,80036SEC ↗

5,000 shares@ US$0.565.8% of flowCOMMON STOCK, PAR VALUE $0.001SEC:0001104659-22-124100:0

Ideal exit: 27 Aug 2023 (T+270)

◆

Chief Financial OfficerExecutives26 Oct 2022Fortress Biotech, Inc.

1,350,000 shares0COMMON STOCK, PAR VALUE $0.001SEC:0001104659-22-112522:0

10 of 10 declarations